Skip to main content

Table 2 Public RNA-seq data chosen for the analysis

From: Unveiling G-protein coupled receptors as potential targets for ovarian cancer nanomedicines: from RNA sequencing data analysis to in vitro validation

Data set accession

Sample size

Type of cells (number of samples)

Cancer samples (all high-grade serous ovarian cancer)

 GSE162714 [24]

77

Pre-chemo (n = 22), Post chemo (n = 55)

 GSE115573

9

Primary (n = 3), Omentum (n = 3), Effusion (n = 3)

 GSE160085 [25]

10

Pre-chemo high grade serous (n = 10)

 GSE98281 [26]

20

Primary (n = 10), Metastatic (n = 10)

 GSE71340 [27]

35

Pre NACT (n = 17), Post NACT (n = 18)

Healthy samples

 GSE114493 [28]

10

Healthy cells (Fallopian (n = 3), Peritoneal (n = 3), Ovarian surface (n = 3))